Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision/version indicator in the footer has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study record details.
    Difference
    0.0%
    Check dated 2026-04-24T06:22:45.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:45:08.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    The page metadata now shows Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T05:13:06.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:47:56.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior government funding operating-status notice (and Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:26:22.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    New site-wide notice about government funding and NIH Clinical Center status appears, and the page revision is updated to v3.4.1; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:41:56.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.